Business Description
Bausch Health Companies Inc
NAICS : 325412
SIC : 3741
ISIN : CA91911K1021
Compare
Compare
Traded in other countries / regions
BHC.CanadaBHC.USABVF.GermanyBHC.MexicoVRX.Switzerland0QYW.UK IPO Date
2014-11-04Description
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | -0.04 | |||||
| Debt-to-Equity | -18.43 | |||||
| Debt-to-EBITDA | 9.44 | |||||
| Interest Coverage | 1.22 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.06 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.6 | |||||
| 3-Year EBITDA Growth Rate | -2.6 | |||||
| 3-Year EPS without NRI Growth Rate | -53.2 | |||||
| 3-Year FCF Growth Rate | -1.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.84 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 197.79 | |||||
| Days Sales Outstanding | 77.79 | |||||
| Days Payable | 81.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.9 | |||||
| Shareholder Yield % | -47.17 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.8 | |||||
| Operating Margin % | 18.65 | |||||
| Net Margin % | -5.11 | |||||
| FCF Margin % | 9.9 | |||||
| ROA % | -1.77 | |||||
| ROIC % | 10.55 | |||||
| 3-Year ROIIC % | -52.72 | |||||
| ROC (Joel Greenblatt) % | 45.61 | |||||
| ROCE % | 4.72 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 32.46 | |||||
| Price-to-Owner-Earnings | 14.79 | |||||
| PS Ratio | 0.33 | |||||
| Price-to-Free-Cash-Flow | 3.38 | |||||
| Price-to-Operating-Cash-Flow | 2.44 | |||||
| EV-to-EBIT | 23.45 | |||||
| EV-to-EBITDA | 10.64 | |||||
| EV-to-Revenue | 2.69 | |||||
| EV-to-FCF | 27.11 | |||||
| Price-to-Projected-FCF | 0.61 | |||||
| Price-to-Median-PS-Value | 0.39 | |||||
| Earnings Yield (Greenblatt) % | 4.26 | |||||
| FCF Yield % | 29.59 | |||||
| Forward Rate of Return (Yacktman) % | 22.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bausch Health Companies Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 8,156.7 | ||
| EPS (TTM) (CHF) | -1.146 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (CHF) | 0 | ||
| 20-Day SMA (CHF) | 122.93991 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (CHF) | 122.93991 - 122.93991 | ||
| Shares Outstanding (Mil) | 367.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bausch Health Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bausch Health Companies Inc Stock Events
| Event | Date | Price(CHF) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bausch Health Companies Inc Frequently Asked Questions
What is Bausch Health Companies Inc(LTS:0QYW)'s stock price today?
The current price of LTS:0QYW is CHF122.94. The 52 week high of LTS:0QYW is CHF122.94 and 52 week low is CHF122.94.
When is next earnings date of Bausch Health Companies Inc(LTS:0QYW)?
The next earnings date of Bausch Health Companies Inc(LTS:0QYW) is 2025-02-21 Est..
Does Bausch Health Companies Inc(LTS:0QYW) pay dividends? If so, how much?
Bausch Health Companies Inc(LTS:0QYW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers